HIV associated nephropathy future or investigational therapies

Jump to navigation Jump to search

HIV associated nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating HIV associated nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

KUB X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

HIV associated nephropathy future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV associated nephropathy future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV associated nephropathy future or investigational therapies

CDC on HIV associated nephropathy future or investigational therapies

HIV associated nephropathy future or investigational therapies in the news

Blogs on HIV associated nephropathy future or investigational therapies

Directions to Hospitals Treating HIV associated nephropathy

Risk calculators and risk factors for HIV associated nephropathy future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]

Overview

Therapies such as molecular targeting require more research.[1] Recently, there have been reports of successful kidney transplantation from HIV-positive donors to HIV-positive recipients.[2][3]

Future or Investigational Therapies

References

  1. 1.0 1.1 1.2 Menez S, Hanouneh M, McMahon BA, Fine DM, Atta MG (2018). "Pharmacotherapy and treatment options for HIV-associated nephropathy". Expert Opin Pharmacother. 19 (1): 39–48. doi:10.1080/14656566.2017.1416099. PMC 6381591. PMID 29224373.
  2. 2.0 2.1 Muller E, Barday Z, Mendelson M, Kahn D (2015). "HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years". N Engl J Med. 372 (7): 613–20. doi:10.1056/NEJMoa1408896. PMC 5090019. PMID 25671253.
  3. 3.0 3.1 Durand CM, Segev D, Sugarman J (2016). "Realizing HOPE: The Ethics of Organ Transplantation From HIV-Positive Donors". Ann Intern Med. 165 (2): 138–42. doi:10.7326/M16-0560. PMC 4949150. PMID 27043422.
  4. Muller E, Barday Z (2018). "HIV-Positive Kidney Donor Selection for HIV-Positive Transplant Recipients". J Am Soc Nephrol. 29 (4): 1090–1095. doi:10.1681/ASN.2017080853. PMC 5875954. PMID 29330339.

Template:WH Template:WS